GO
Loading...

Edwards Lifesciences Corp

More

  • July 29- Edwards Lifesciences Corp posted stronger second-quarter earnings on Tuesday, propelled by a gain from a legal settlement and higher sales of heart valves that are implanted using a less-invasive procedure than traditional open-heart surgery.

  • July 29- Edwards Lifesciences Corp posted stronger second-quarter earnings on Tuesday, propelled by a gain from a legal settlement and higher sales of heart valves that are implanted using a less-invasive procedure than traditional open-heart surgery.

  • June 16- Edwards Lifesciences Corp said on Monday that U.S. health regulators approved its next generation heart valve replacement system for high risk patients and those deemed too frail to endure open heart surgery.

  • June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.

  • June 12- Medtronic Inc said on Thursday its minimally invasive heart valve replacement system received U.S. approval to treat patients deemed at high risk for surgery, expanding the eligible patient population for its CoreValve device.

  • May 20- Medtronic Inc agreed to pay more than $1 billion to rival Edwards Lifesciences Corp to settle patent litigation and keep its CoreValve artificial heart valve on the U.S. market. Edwards was first to market with its Sapien technology in 2011 in the United States, while Medtronic received U.S. regulatory approval for CoreValve in January.

  • Midday movers: General Motors, Caterpillar & More Tuesday, 20 May 2014 | 1:01 PM ET

    Some of Tuesday's midday movers:

  • May 20- Medtronic Inc agreed to pay royalties to rival Edwards Lifesciences Corp so it can continue to sell its CoreValve replacement heart valves, the medical device maker said on Tuesday. Medtronic said it would give Edwards a one-time payment of $750 million, plus ongoing royalty payments through April 2022, based on a percentage of CoreValve sales.

  • May 20- Medtronic Inc said on Tuesday it agreed to pay royalties to rival medical device maker Edwards Lifesciences Corp in a settlement that allows Medtronic to continue to sell its CoreValve replacement heart valves.

  • COLUMN-When the best offense is defensive stocks Wednesday, 23 Apr 2014 | 4:30 PM ET

    LONG BEACH, Calif., April 23- You've been on offense with your global stock portfolio for five years, running up the score in sectors like consumer discretionary and technology stocks that have outperformed the broad market. Jamie Doyle, co-manager of the Causeway Global Value Fund, is not ready to make a wholesale switch into defensive plays.

  • April 21- A U.S. appeals court on Monday postponed an injunction that would have stopped Medtronic Inc from selling its CoreValve heart valve implant in competition with Edwards Lifesciences Corp's Sapien valve product.

  • *Citigroup is one of S&P's biggest gainers after results. NEW YORK, April 14- U.S. stocks closed higher on Monday as Citigroup's earnings and strong retail sales gave investors reasons to buy equities despite a resurgence of geopolitical uncertainties.

  • *Citigroup one of S&P's biggest gainers after results. NEW YORK, April 14- U.S. stocks rose on Monday, rebounding after a sharp selloff in the previous session as strong results from Citigroup and bullish retail sales data lifted sentiment.

  • Midday movers: Twitter, General Motors, Visa & More Monday, 14 Apr 2014 | 1:04 PM ET
    The Twitter banner hangs at the NYSE.

    Some of Monday midday movers:

  • April 14- Shares of medical device maker Medtronic Inc fell as much as 6 percent after a U.S. court temporarily halted sales of its aortic heart valve replacement system in the country.

  • NEW YORK, April 14- U.S. stocks bounced back on Monday, following a sharp selloff last session, with earnings results from Citigroup and retail sales data lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

  • Early movers: C, MSFT, JNJ, LLY, V & more Monday, 14 Apr 2014 | 9:07 AM ET
    Traders on the floor of the New York Stock Exchange.

    These are the companies making headlines before the bell.

  • NEW YORK, April 14- U.S. stocks were set to open higher on Monday, following a sharp selloff last session, with earnings results from Citigroup and retail sales data lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

  • *Edwards Lifesciences shares rally after court ruling. *Ukraine's acting president threatens military action. NEW YORK, April 14- U.S. stock index futures edged higher on Monday, following a slarge selloff last session, with earnings results from Citigroup lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

  • Medical appliance stocks: Analyst shares her picks Friday, 4 Apr 2014 | 12:46 PM ET
    An Edwards Lifesciences Corp. SAPIEN transcatheter heart valve is assembled in a training room at company headquarters in Irvine, Calif.

    Shagun Chadha shares her top pick among medical appliance companies and gives other sector names she likes as well.